Merck (XPAR:MRK) Cash Flow from Discontinued Operations : €0 Mil (TTM As of Dec. 2023)

View and export this data going back to 1946. Start your Free Trial

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Merck's cash flow from discontinued operations for the three months ended in Dec. 2023 was €0 Mil. It means Merck received €0 Mil from the sale of part of business quarterly. Merck's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Dec. 2023 was €0 Mil.

Merck Cash Flow from Discontinued Operations Historical Data

The historical data trend for Merck's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow from Discontinued Operations

Get a 7-Day Free Trial

Merck Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash Flow from Discontinued Operations	Get a 7-Day Free Trial															-	-	-	-	-

Merck Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

Merck Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Merck's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck (XPAR:MRK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (XPAR:MRK) » Definitions » Cash Flow from Discontinued Operations

Comparable Companies

Traded in Other Exchanges

MRK:USA MRK:Peru MRK:Mexico 1MRKX:Italy 6MKd:UK 0QAH:UK 6MK:Germany 6MK:Germany 6MK:Germany 6MK:Germany MRK:Chile MRCK34:Brazil MRK:Austria MRK:Argentina

Address

126 East Lincoln Avenue, Rahway, NJ, USA, 07065

Website

https://www.merck.com

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.